SAN DIEGO, April 14, 2023 /PRNewswire/ -- NuVasive, Inc. NUVA, the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that leading independent proxy advisory firm Institutional Shareholder Services ("ISS") recommends that NuVasive shareholders vote "FOR" the shareholder proposal to adopt the merger agreement with Globus Medical GMED at NuVasive's upcoming special meeting of shareholders ("the special meeting") scheduled for April 27, 2023. Only holders of record of NuVasive common stock as of the close of business on March 24, 2023 are entitled to vote at the special meeting.